Bausch + Lomb Corporation Common Shares (NY:BLCO)

17.15 -0.19 (-1.10%)

Official Closing Price Updated: 7:00 PM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bausch + Lomb Corporation Common Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Wall Street Remains On Track For AMD-Led Rebound Ahead Of Fed Decision, Meta Earnings: Analyst Says 'The Bull Tends To Remain' Despite Near-Time Volatility ↗

July 31, 2024

Tech optimism is likely to abound on Wall Street as AI-levered stocks are feeding off the strength generated by Advanced Micro Devices, Inc.‘s (NASDAQ:AMD)

Via Benzinga

Topics Economy

Bausch + Lomb Announces Second-Quarter 2024 Results

July 31, 2024

From Bausch + Lomb Corporation

Via Business Wire

Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings ↗

July 29, 2024

The unfolding week's market trajectory depends on earnings from bellwether tech stocks and what the Fed has to say following its July meeting.

Via Benzinga

Topics Economy

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week ↗

April 29, 2024

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.

Via Benzinga

Topics Stocks

Barclays Maintains Equal-Weight Rating for Bausch & Lomb: Here's What You Need To Know ↗

February 26, 2024

Via Benzinga

Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 24, 2024

Via Benzinga

Bausch + Lomb Will Release Second-Quarter 2024 Financial Results on July 31

July 11, 2024

From Bausch + Lomb Corporation

Via Business Wire

Millions of Americans Experience Dry Eye Symptoms, Yet New National Survey Shows Sufferers Struggle to Find Relief

July 08, 2024

From Bausch + Lomb Corporation

Via Business Wire

Why Is Clearside Biomedical Stock Gaining Today? ↗

June 25, 2024

Clearside Biomedical pioneers suprachoroidal drug delivery for precise, effective treatment of retinal diseases. Oppenheimer rates CLSD Outperform with a $5 target, citing its innovative SCS...

Via Benzinga

Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress

June 17, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States

June 10, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States

June 03, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results

May 29, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®

May 28, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens

May 28, 2024

From Bausch + Lomb Corporation

Via Business Wire

Do You Have Your Eye On Vision Care Stocks? ↗

May 20, 2024

For investors seeking stable and growing opportunities, eye care stocks are an attractive option.

Via Talk Markets

American Airlines To Rally Around 59%? Here Are 10 Top Analyst Forecasts For Monday ↗

May 06, 2024

Via Benzinga

BLCO Stock Earnings: Bausch & Lomb Meets EPS, Misses Revenue for Q1 2024 ↗

May 01, 2024

BLCO stock results show that Bausch & Lomb met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Bausch + Lomb Announces First-Quarter 2024 Results

May 01, 2024

From Bausch + Lomb Corporation

Via Business Wire

Wall Street Set To Open Lower After AMD Earnings Disappoint As Traders Look To Fed's Powell For Relief: Why This Analyst Sees Incoming Summer Rally ↗

May 01, 2024

A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.‘s (NASDAQ:AMD)

Via Benzinga

Topics Economy

Bausch + Lomb Announces Presentation of New Data at the Association for Research in Vision and Ophthalmology Annual Meeting

April 29, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Statistically Significant Results From a Clinical Study of a Novel Daily Nutritional Supplement for Dry Eyes

April 25, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Reports More Than 84 Million Units of Contact Lenses, Lens Care and Eye Care Materials Collected Through Innovative Recycling Programs

April 18, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Release First-Quarter 2024 Financial Results on May 1

April 15, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting

March 27, 2024

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Appointment of Karen L. Ling to Board of Directors

February 28, 2024

From Bausch + Lomb Corporation

Via Business Wire

Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 21, 2024

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly...

Via Benzinga

Eye Care-Focused Bausch + Lomb's Stock Surges On Upbeat Annual Guidance Despite Deeper Losses ↗

February 21, 2024

Bausch + Lomb achieves Q4 2023 sales of $1.173 billion, exceeding expectations with an 18% YoY growth. CEO Brent Saunders anticipates robust growth in 2024, projecting sales of $4.6-$4.7 billion and an...

Via Benzinga

Toll Brothers Posts Upbeat Earnings, Joins Exelon, Garmin, Bausch + Lomb And Other Big Stocks Moving Higher On Wednesday ↗

February 21, 2024

U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday.

Via Benzinga

Topics Stocks

Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO

February 21, 2024

From Emergent BioSolutions

Via GlobeNewswire

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.